Literature DB >> 15491293

Measuring T cell immunity to influenza vaccination in children after haemopoietic stem cell transplantation.

W Nicholas Haining1, John W Evans, Nilufer P Seth, G Derek Callaway, Kai W Wucherpfennig, Lee M Nadler, Eva C Guinan.   

Abstract

Quantitative assessment of immunogen-specific T cell responses may provide a meaningful surrogate marker of functional immunity in patients following haemopoietic stem cell transplantation (HSCT). We developed a flow-cytometric assay to quantify antigen-specific T cell immunity to influenza-A and studied the T cell response to influenza vaccination in five children, 3-21 months post-HSCT. All patients showed an increase in influenza-A-specific CD4(+) immunity following vaccination while none had a detectable IgG response to the vaccine. This assay proved sufficiently sensitive to evaluate changes in T cell memory in immunocompromised individuals and could be used to better characterize post-HSCT immune reconstitution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15491293      PMCID: PMC4516023          DOI: 10.1111/j.1365-2141.2004.05204.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

1.  Haploidentical 'megadose' CD34+ cell transplants for patients with acute leukemia.

Authors:  M F Martelli; Y Reisner
Journal:  Leukemia       Date:  2002-03       Impact factor: 11.528

2.  HLA class II-restricted CD4+ T cell responses directed against influenza viral antigens postinfluenza vaccination.

Authors:  Nancy A Danke; William W Kwok
Journal:  J Immunol       Date:  2003-09-15       Impact factor: 5.422

3.  pH-triggered microparticles for peptide vaccination.

Authors:  W Nicholas Haining; Daniel G Anderson; Steven R Little; Michael S von Bergwelt-Baildon; Angelo A Cardoso; Pedro Alves; Kostas Kosmatopoulos; Lee M Nadler; Robert Langer; Daniel S Kohane; Michael S von Berwelt-Baildon
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

Review 4.  Similarities and differences in CD4+ and CD8+ effector and memory T cell generation.

Authors:  Robert A Seder; Rafi Ahmed
Journal:  Nat Immunol       Date:  2003-09       Impact factor: 25.606

Review 5.  Vaccination against infectious disease following hematopoietic stem cell transplantation.

Authors:  D Avigan; L A Pirofski; H M Lazarus
Journal:  Biol Blood Marrow Transplant       Date:  2001       Impact factor: 5.742

6.  High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution.

Authors:  Suparno Chakrabarti; Stephen Mackinnon; Raj Chopra; Panagiotis D Kottaridis; Karl Peggs; Peter O'Gorman; Ronjon Chakraverty; Timothy Marshall; Husam Osman; Premini Mahendra; Charles Craddock; Herman Waldmann; Geoff Hale; Christopher D Fegan; Kwee Yong; Anthony H Goldstone; David C Linch; Donald W Milligan
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

7.  Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers.

Authors:  Cheryl L Day; Nilufer P Seth; Michaela Lucas; Heiner Appel; Laurent Gauthier; Georg M Lauer; Gregory K Robbins; Zbigniew M Szczepiorkowski; Deborah R Casson; Raymond T Chung; Shannon Bell; Gillian Harcourt; Bruce D Walker; Paul Klenerman; Kai W Wucherpfennig
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

8.  A sensitive method for detecting proliferation of rare autoantigen-specific human T cells.

Authors:  Stuart I Mannering; Jessica S Morris; Kent P Jensen; Anthony W Purcell; Margo C Honeyman; Peter M van Endert; Leonard C Harrison
Journal:  J Immunol Methods       Date:  2003-12       Impact factor: 2.303

Review 9.  Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients.

Authors:  L Ochs; X O Shu; J Miller; H Enright; J Wagner; A Filipovich; W Miller; D Weisdorf
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

Review 10.  The role of haploidentical stem cell transplantation in the management of children with haematological disorders.

Authors:  Paul Veys; Persis Amrolia; Kanchana Rao
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998

  10 in total
  10 in total

1.  CD154 expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults.

Authors:  Aprille Seidel; David Smith; Edward Yung; Lia Aquino; Tumul Srivastava; Vinod Pullarkat; Ricardo Spielberger; Stephen J Forman; Don J Diamond
Journal:  Biol Blood Marrow Transplant       Date:  2010-05-08       Impact factor: 5.742

2.  Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Bilal Mohty; Michael Bel; Marija Vukicevic; Monika Nagy; Emmanuel Levrat; Sara Meier; Stephane Grillet; Christophe Combescure; Laurent Kaiser; Yves Chalandon; Jakob Passweg; Claire-Anne Siegrist; Eddy Roosnek
Journal:  Haematologica       Date:  2011-03-21       Impact factor: 9.941

3.  Antigen-specific immune responses to influenza vaccine in utero.

Authors:  Deepa Rastogi; Chaodong Wang; Xia Mao; Cynthia Lendor; Paul B Rothman; Rachel L Miller
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

4.  A pilot randomized trial of adjuvanted influenza vaccine in adult allogeneic hematopoietic stem cell transplant recipients.

Authors:  Y Natori; A Humar; J Lipton; D D Kim; P Ashton; K Hoschler; D Kumar
Journal:  Bone Marrow Transplant       Date:  2017-03-06       Impact factor: 5.483

5.  Ibrutinib may impair serological responses to influenza vaccination.

Authors:  Abby P Douglas; Jason A Trubiano; Ian Barr; Vivian Leung; Monica A Slavin; Constantine S Tam
Journal:  Haematologica       Date:  2017-06-28       Impact factor: 9.941

6.  Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia.

Authors:  W Nicholas Haining; Donna S Neuberg; Heather L Keczkemethy; John W Evans; Stephen Rivoli; Rebecca Gelman; Howard M Rosenblatt; William T Shearer; Javier Guenaga; Daniel C Douek; Lewis B Silverman; Stephen E Sallan; Eva C Guinan; Lee M Nadler
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

7.  Contemporary analysis of functional immune recovery to opportunistic and vaccine-preventable infections after allogeneic haemopoietic stem cell transplantation.

Authors:  Harini D de Silva; Rosemary A Ffrench; Maya Korem; Eva Orlowski; David J Curtis; Andrew Spencer; Sharon Avery; Sushrut Patil; Catherine Orla Morrissey
Journal:  Clin Transl Immunology       Date:  2018-10-05

8.  Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients.

Authors:  Nathalie Dhédin; Anne Krivine; Nicole Le Corre; Alain Mallet; Bruno Lioure; Jacques-Olivier Bay; Marie-Thérèse Rubio; Philippe Agape; Anne Thiébaut; Jérôme Le Goff; Brigitte Autran; Patricia Ribaud
Journal:  Vaccine       Date:  2013-12-12       Impact factor: 3.641

9.  Significant Transplantation-Related Mortality from Respiratory Virus Infections within the First One Hundred Days in Children after Hematopoietic Stem Cell Transplantation.

Authors:  Sakara Hutspardol; Mohammed Essa; Susan Richardson; Tal Schechter; Muhammad Ali; Joerg Krueger; Hisaki Fujii; R Maarten Egeler; Adam Gassas
Journal:  Biol Blood Marrow Transplant       Date:  2015-06-25       Impact factor: 5.742

10.  Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial.

Authors:  Claudia Spies; Alawi Luetz; Gunnar Lachmann; Markus Renius; Clarissa von Haefen; Klaus-Dieter Wernecke; Marcus Bahra; Alexander Schiemann; Marco Paupers; Christian Meisel
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.